DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Sign in and take the values quiz to see how this bill lines up with what you've said.
The bill requires the Drug Enforcement Administration to temporarily exempt buprenorphine products from the Suspicious Orders Report System until 270 days after the opioid public health emergency expires. The exemption is intended to increase access to buprenorphine treatment by removing reporting requirements that may discourage pharmacies from stocking the medication. Within 90 days of the emergency's expiration, the Departments of Justice and Health and Human Services must report on whether the exemption increased treatment access and recommend whether the exemption should become permanent.
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
Sign in to see how your representatives voted on this bill.